Want to use our logo?

Download the ICS Branding Pack

ICS Background

Dr Kazumasa Torimoto
Nara Medical University

ICS 2020

Open Discussion ePoster Session 25 ePoster 6 384 The effects of a herbal medicine, Choreito, on a model of nocturnal polyuria in Dahl salt-sensitive rats fed with a 2%-salt diet

Podium Short Oral Session 37 Urodynamics and Best of the Rest 587 A trial to develop serum biomarkers for interstitial cystitis/bladder pain syndrome

ICS 2019

Podium Short Oral Session 27 Bladder Wall, Microbiome and Nocturia 515 The Dahl salt-sensitive rat as a model of nocturnal polyuria

ICS 2016

Podium Express Session 22 Rapid Communications in Conservative Management 412 A novel handheld home-uroflowmetry, P-Flowdiary®

ICS 2015

Podium Short Oral Session 34 Pharmacotherapy for Overactive Bladder 487 Clinical efficacy and safety of a beta3-adrenoceptor agonist (mirabegron) and an antimuscarinic agent (imidafenacin) in female patients with overactive bladder: a randomized crossover study

ICS 2014

Open Discussion Poster Session 11 Lower Urinary Tract Symptoms in Women 118 Clinical efficacy and safety of a beta3-adrenoceptor agonist and an antimuscarinic agent in female patients with overactive bladder: a randomized crossover study (An interim report)

ICS 2013

Podium Poster Session 30 Nocturia 2 273 Influence of lower urinary tract symptoms on sleep disorder and general health-related quality of life in elderly subjects

ICS 2012

Podium Poster Session 22 Gerontology 197 Evaluation of sleep quantity and quality in older adults with nocturia using portable electroencephalogram acquisition device

ICS 2011

Non Discussion Abstract Session 31 Read by Title 773 Five teenaged cases with interstitial cystitis-like lower urinary tract symptoms relieved by hydrodistention

ICS/IUGA 2010

Non Discussion Abstract Session 33 Read by Title 891 Anti-muscarinics can improve OAB-induced hypertension.

Kazumasa Torimoto

Member

Profession:Urologist
Qualifications:Staff Member
Privacy:
You must be logged in to view this contact
Sign-in to ICS
NO DISCLOSURE STATEMENT RECORDED
VOLUNTARY